Discussão do artigo "Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia" de <a href="https://pubmed.ncbi.nlm.nih.gov/?term=DeZern+AE&cauthor_id=32343796">Amy E DeZern</a>, publicado Blood. 2023 Jun 22;141(25):3031-3038. doi: 10.1182/blood.2023020435.
Apresentado pelo Dr Diego Luz

Discussão do artigo "Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia" de Amy E DeZern, publicado Blood. 2023 Jun 22;141(25):3031-3038. doi: 10.1182/blood.2023020435. Apresentado pelo Dr Diego Luz

Discussão do artigo "Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia" de <a href="https://pubmed.ncbi.nlm.nih.gov/?term=DeZern+AE&amp;cauthor_id=32343796" rel="noopener noreferrer">Amy E DeZern</a>, publicado Blood.&nbsp;2023 Jun 22;141(25):3031-3038.&nbsp;doi: 10.1182/blood.2023020435.
Apresentado pelo Dr Diego Luz

Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Share Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia

Sign up to save your podcasts

Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia

Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia